RICE HALL JAMES & ASSOCIATES, LLC AUPH AURINIA PHARMACEUTICALS INC

Ownership history in RICE HALL JAMES & ASSOCIATES, LLC  ·  5 quarters on record

AI Ownership Summary

RICE HALL JAMES & ASSOCIATES, LLC reported AURINIA PHARMACEUTICALS INC (AUPH) in 5 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 0.44% in 2025 Q4. The latest visible filing shows AUPH at 0.40% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this AUPH ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was RICE HALL JAMES & ASSOCIATES, LLC's position in AURINIA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

AUPH was reported at 0.40% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.44% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How RICE HALL JAMES & ASSOCIATES, LLC held AUPH — position size vs. price
% of Fund (quarterly)    AUPH price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 487,898 -7,738 -1.6% 0.40% $7.2M 2026-05-15 $15.28
2025 Q4 REDUCED 8.6% -7.1% 495,636 -46,919 -8.6% 0.44% $7.9M 2026-02-17 $14.31
2025 Q3 REDUCED 542,555 -7,946 -1.4% 0.33% $6.0M 2025-10-16 $11.55
2025 Q2 ADDED 550,501 +325,031 +144.2% 0.25% $4.7M 2025-08-11 $11.43
2025 Q1 INITIATED 225,470 0.11% $1.8M 2025-05-01 $8.20

FAQ About RICE HALL JAMES & ASSOCIATES, LLC and AUPH

These are the practical questions this page is built to answer before you even open the full history table.

How long has RICE HALL JAMES & ASSOCIATES, LLC reported owning AUPH?

RICE HALL JAMES & ASSOCIATES, LLC reported AUPH across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported AUPH position in RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

The largest reported portfolio weight for AUPH was 0.44% in 2025 Q4.

What is the latest reported AUPH position on this page?

The most recent filing on this page is 2026 Q1, when RICE HALL JAMES & ASSOCIATES, LLC reported 487,898 shares, equal to 0.40% of portfolio, with an estimated market value of $7.2M.

What does the chart on this AUPH ownership page compare?

The chart compares RICE HALL JAMES & ASSOCIATES, LLC's quarterly AUPH portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did RICE HALL JAMES & ASSOCIATES, LLC time their AUPH position?

Based on 13F filing dates vs. subsequent AUPH price moves, RICE HALL JAMES & ASSOCIATES, LLC correctly timed 2 out of 4 reported position changes (50%). The annualised alpha on AUPH relative to SPY over the holding period was +37.5%.

← Back to RICE HALL JAMES & ASSOCIATES, LLC Holdings